
The University of Cape Town (UCT) is offering prestigious postdoctoral fellowships at its Holistic Drug Discovery and Development Centre (H3D). As Africa’s first integrated drug discovery center, H3D provides a world-class environment for chemists to work on life-saving treatments for Malaria, Tuberculosis (TB), and Antimicrobial Resistance (AMR).
Research Focus & Mentorship
This role is designed for researchers looking to bridge the gap between Synthetic Organic Chemistry and Clinical Application. Fellows will be trained to:
- Compound Design: Use biological data and DMPK (Drug Metabolism and Pharmacokinetics) to design potent drug leads.
- Advanced CADD: Utilize Computer-Aided Drug Discovery and AI/ML for structural optimization.
- SAR Studies: Conduct Structure-Activity Relationship (SAR) studies to refine chemical scaffolds.
Fellowship Details at a Glance
| Feature | Details |
| Location | H3D, University of Cape Town, South Africa |
| Research Areas | Synthetic Organic Chemistry, Medicinal Chemistry, Infectious Diseases |
| Value | R367,500 – R410,000 (Tax-Free) |
| Duration | 1 Year (Renewable based on progress and funds) |
| Deadline | 28 February 2026 |
Eligibility Criteria
- Education: PhD in Synthetic Organic or Medicinal Chemistry obtained within the last 3 years.
- Experience: Proven track record in multi-step organic synthesis and synthetic methodologies, supported by publications in international journals.
- Exclusions: Applicants must not have held a full-time permanent academic or professional post previously.
- Residency: Must be prepared to reside in Cape Town for the duration of the fellowship.
Application Process
Applications must be submitted as a single PDF file to Ms. Chanté Foentjies (chante.foentjies@uct.ac.za) addressed to Professor Kelly Chibale.
Required Documents:
- Cover Letter (1 Page): Outlining expertise, research interests, and relevant experience.
- CV: Summarizing research work and listing all publications.
- Transcripts: Copies of all academic records.
- References: Contact details of previous supervisors or academic colleagues.
Why H3D?
Joining H3D connects you to a global network of leading scientists. The center gained international acclaim for developing MMV048, the first clinical antimalarial candidate discovered by an African-led team. You will have access to state-of-the-art facilities and cross-disciplinary mentorship in enzymology and disease-focused biology.
